1. Home
  2. XBIT vs BDL Comparison

XBIT vs BDL Comparison

Compare XBIT & BDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.37

Market Cap

74.4M

Sector

Health Care

ML Signal

HOLD

Logo Flanigan's Enterprises Inc.

BDL

Flanigan's Enterprises Inc.

N/A

Current Price

$38.33

Market Cap

63.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
XBIT
BDL
Founded
2005
1959
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
74.4M
63.2M
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
XBIT
BDL
Price
$2.37
$38.33
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
25.1K
3.3K
Earning Date
05-08-2026
05-18-2026
Dividend Yield
N/A
1.90%
EPS Growth
N/A
49.72
EPS
N/A
1.98
Revenue
N/A
$205,248,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$21.37
Revenue Growth
N/A
8.99
52 Week Low
$2.09
$26.33
52 Week High
$3.61
$42.31

Technical Indicators

Market Signals
Indicator
XBIT
BDL
Relative Strength Index (RSI) 48.81 68.08
Support Level $2.35 $29.14
Resistance Level $2.41 N/A
Average True Range (ATR) 0.05 1.54
MACD 0.00 0.82
Stochastic Oscillator 40.79 89.52

Price Performance

Historical Comparison
XBIT
BDL

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About BDL Flanigan's Enterprises Inc.

Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.

Share on Social Networks: